Echo IQ seen facing selloff after FDA clearance denial
Petra Capital says Echo IQ shares are likely to be sold today after the U.S. FDA didn’t clear its EchoSolv HF heart-failure detection tool. The regulator issued a Not Substantially Equivalent determination.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.